Hs-CRP is associated with Heart Failure Hospitalization in Patients with MAFLD and Normal LVEF Undergoing Coronary Angiography DOI Open Access
Xiaodong Zhou, Qin‐Fen Chen, Giovanni Targher

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2023, Volume and Issue: unknown

Published: Oct. 7, 2023

Abstract Background Systemic chronic inflammation plays a role in the pathophysiology of both heart failure with preserved ejection fraction (HFpEF) and metabolic dysfunction-associated fatty liver disease (MAFLD). Aim This study aimed to investigate whether serum high-sensitivity C-reactive protein (hs-CRP) levels were associated future risk (HF) hospitalization patients MAFLD normal left ventricular (LVEF). Methods The enrolled consecutive individuals LVEF who underwent coronary angiography for suspected disease. population was subdivided into non-HF, pre-HFpEF, HFpEF groups at baseline. outcome first HF. Results In 10,019 middle-aged (mean age 63.3±10.6 years; 38.5% female), prevalence rates pre-HFpEF 34.2% 34.5%, median hs-CRP level 4.5 mg/L (IQR: 1.9-10 mg/L) 5.0 2.1-10.1 mg/L), respectively. Serum significantly higher than non-HF group. HF hospitalizations occurred 1942 (19.4%) over 3.2 years, 3.7% 20.8% 32.1% HFpEF, Cox regression analyses showed that highest quartile had ∼4.5-fold increased being hospitalized compared those lowest (adjusted-Hazard Ratio 4.42, 95% CI 3.72-5.25). Conclusions There high baseline subjects MAFLD. an elevated levels.

Language: Английский

Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Disease: Pathophysiological Mechanisms DOI

家亮 范

Advances in Clinical Medicine, Journal Year: 2024, Volume and Issue: 14(03), P. 1429 - 1436

Published: Jan. 1, 2024

Language: Английский

Citations

0

The Paradox of Physical Activity and Coronary Artery Calcification: Implications for Cardiovascular Risk DOI Open Access

Da-Eun Sung,

Ki‐Chul Sung

Journal of Clinical Medicine, Journal Year: 2024, Volume and Issue: 13(21), P. 6523 - 6523

Published: Oct. 30, 2024

The introduction of CT scans and the subsequent Agatston score in 1990s drastically improved our ability to detect coronary artery calcification (CAC). This led its incorporation into cardiovascular risk assessment guidelines set forth by organizations such as American Heart Association (AHA) College Cardiology (ACC). Over time, these have evolved significantly, reflecting an increasing understanding CAC. Physical activity has become a key factor management disease. However, relationship between physical CAC remains complex. Although is generally beneficial for health, paradoxically, high levels been associated with elevated scores. higher may indicate presence more stable, calcified plaques that provide protection against plaque rupture. These contradictory findings call balanced interpretations acknowledge benefits activity. review examines historical development clinical CAC, paradoxical potential underlying mechanisms. It emphasizes need future research utilize objective measures consistent methodologies better understand

Language: Английский

Citations

0

Hs-CRP is associated with Heart Failure Hospitalization in Patients with MAFLD and Normal LVEF Undergoing Coronary Angiography DOI Open Access
Xiaodong Zhou, Qin‐Fen Chen, Giovanni Targher

et al.

medRxiv (Cold Spring Harbor Laboratory), Journal Year: 2023, Volume and Issue: unknown

Published: Oct. 7, 2023

Abstract Background Systemic chronic inflammation plays a role in the pathophysiology of both heart failure with preserved ejection fraction (HFpEF) and metabolic dysfunction-associated fatty liver disease (MAFLD). Aim This study aimed to investigate whether serum high-sensitivity C-reactive protein (hs-CRP) levels were associated future risk (HF) hospitalization patients MAFLD normal left ventricular (LVEF). Methods The enrolled consecutive individuals LVEF who underwent coronary angiography for suspected disease. population was subdivided into non-HF, pre-HFpEF, HFpEF groups at baseline. outcome first HF. Results In 10,019 middle-aged (mean age 63.3±10.6 years; 38.5% female), prevalence rates pre-HFpEF 34.2% 34.5%, median hs-CRP level 4.5 mg/L (IQR: 1.9-10 mg/L) 5.0 2.1-10.1 mg/L), respectively. Serum significantly higher than non-HF group. HF hospitalizations occurred 1942 (19.4%) over 3.2 years, 3.7% 20.8% 32.1% HFpEF, Cox regression analyses showed that highest quartile had ∼4.5-fold increased being hospitalized compared those lowest (adjusted-Hazard Ratio 4.42, 95% CI 3.72-5.25). Conclusions There high baseline subjects MAFLD. an elevated levels.

Language: Английский

Citations

0